39.55 22.68 39.74 11.38 38.23 21.35 1.60 4.05 Administrative expenses 10.36 3.00 7.19 4.12 10.31 2.95 6.68 3.73 3.17 44.09 Profit before financing costs and income tax expense 53.07 15.35 18.07 10.36

Portal by the Office of the Securities and Exchange Commission. Thus, all group company are ready for full business operation.  The Company’s financing cost decreased Baht 6.11 million from lower

acquisitions of property, plant and equipment 12.6 million. (4.3) Cash Flows from Financing Activities The Company has net cash flows used in financing activities for the nine-month period as of September 30

% 25% 1% 28% 25% 3% Other income /(expenses) 15.00 5.09 195% 130.99 23.62 455% Financing cost 0.02 3.58 -99% 4.34 12.03 -64% Corporate Tax 20.58 7.81 163% 99.30 56.44 76% Net profit 81.86 70.04 17

compensation rates of medical staff secured for the future business expansion. Financing Costs The Company and its subsidiary’s financing costs in relation to the loans from financial institutions and related

Cash Equivalent on 1st January 60.6 76.8 Net Cash Provided (Used in) Operating Activities 26.9 24.4 Net Cash Provided (Used in) Investing Activities (0.8) (79.8) Net Cash Provided (Used in) Financing

60.6 76.8 Net Cash Provided (Used in) Operating Activities 45.4 14.3 Net Cash Provided (Used in) Investing Activities (38.7) (105.5) Net Cash Provided (Used in) Financing Activities (23.5) 78.9 Net Cash

% Administrative expenses 41.64 47.84 -13% EBITDA 140.29 96.18 46% % EBITDA 31% 25% 6% Other income /(expenses) 104.78 9.48 1005% Financing cost 2.61 0.30 767% Corporate Tax 44.31 17.82 149% Net profit 176.67 69.08

Flows from Financing Activities Net cash used in financing activities was 59.3 million baht for the nine-month period as at September 30, 2018. The company has dividend payment was 11.2 million baht

- - 0% 20.31 10.66 90% EBITDA * 129.92 111.83 16% 379.61 294.81 29% % EBITDA * 28% 26% 2% 29% 25% 4% Other income /(expenses) 5.65 4.33 30% 115.99 18.53 526% Financing cost 0.48 3.83 -87% 4.32 8.45 -49